Track the 티앤엘 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 티앤엘 has recorded 1 public disclosures. Market capitalisation: €461.8bn. The latest transaction was filed on 9 April 2026 (Other). Among the most active insiders: 최윤소. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
티앤엘 es una empresa que opera en el sector de la salud y farmacéutico, cotizando en el mercado XKRX. Se enfoca en el desarrollo de soluciones innovadoras para el bienestar y la salud del paciente.